MINNEAPOLIS, MedicalCV, Inc.

MedicalCV, Inc.

* Work with our hospital customers to assure acceptance of reprocessing
through an evidence-based educational campaign that communicates the
benefits of reprocessing in terms of reducing hospital costs and medical
waste.

throat skeletons

0200, ext.

orthopaedic anesthesia

from August 2002 until St., a cardiovascular surgery device manufacturer, focuses on
the development and introduction of products designed to improve patient
outcomes through the early treatment of cardiovascular disorders and disease
specifically , products used by cardiac surgeons to ablate cardiac tissue as a
potential means to treat atrial fibrillation. The ATRILAZE(TM) system is being utilized for concomitant open-heart
surgical procedures ., please visit
http://www. AMDR member companies
reprocess for America's best hospitals, as listed by U. A forward-looking statement should not be regarded as a
representation by the Company that the results described therein will
be achieved.

demonstrating skeletal

com, a cardiovascular surgery
device manufacturer , announced today that its Board of Directors elected Larry
G.495.

* Continue to help our hospital customers protect the environment by
reducing their medical waste.
While various orthopaedic manufacturers and surgeons have
developed MIS techniques for total hip surgery, most have not
addressed the common surgical challenges associated with the use of a
smaller incision .

throat constructing

(OTC Bulletin Board: MDCV), http://www. Haimovitch and J.
Mr. The Company's core technology
is the ATRILAZE(TM) Surgical Ablation System for use in cardiac tissue
ablation procedures in open-heart surgery.wmt. The forward-looking
statements are made as of the date of this press release .

anatomical gpi

To date, over 25 million medical devices have
been reprocessed by our members for hundreds of the nation's hospitals,
including 13 of the 14 "honor roll" hospitals, as identified by US News +
World Report.

* Inspect each and every reprocessed medical device to ensure patient
safety and functional integrity, before releasing it to a hospital.

* Continue to conduct our manufacturing operations in conformance with
FDA's stringent manufacturing and quality assurance requirements , in
order to maintain the outstanding safety record that third-party
reprocessing has enjoyed since its inception.S." AMDR members reprocess for 13 of those 14
hospitals. The PATH (TM) technique is
also compatible with the advanced bearing surface options of Wright's
LINEAGE (R) Acetabular System, as well as its unique BFH(TM) (Big
Femoral Head) Technology.
All statements made in this press release, other than statements of
historical fact, are forward-looking statements . Although the Company
believes that the forward-looking statements are accurate, there can
be no assurance that any forward-looking statement will prove to be
accurate.

nose simulators

Jude
Medical acquired Endocardial Solutions in March 2005.452." Manufacturers frequently choose to label their products
this way because they make more money if the hospital throws out each
device after one use. The technique and
instrumentation are some of the most recent innovations of Wright's
ODYSSEY (TM) Tissue Preserving Initiative, a minimally invasive surgery
program for hip, knee and total joint resurfacing procedures.

zoological sawbones

You may register to receive MedicalCV's future press releases and to be
added to the Company's distribution list by visiting:
http://www.

C., an
accomplished orthopaedic surgeon and renowned pioneer in the field of
less invasive joint replacement surgery .
Since its introduction, the program has been expanded to include a new
stem design - the PROFEMUR (R) Tapered Stem - an innovative technique
and instrumentation for less invasive total knee procedures , and now
the PATH(TM) approach to total hips.

breathing constructing

MedicalCV Elects Larry Haimovitch and Robert Paulson to Board of Directors

Prior to joining Restore Medical in April
2005, Mr. Paulson served as Chief Financial Officer and Vice President of
Marketing for Endocardial Solutions, Inc."
For further information on MedicalCV, Inc.com/form.amdr.

Business Editors/Health/Medical Writers
72nd Annual American Academy of Orthopaedic Surgeons Meeting

ARLINGTON, Tenn.

demonstrating knee

His
firm , whose current area of emphasis includes minimally invasive surgical
technologies, specializes in the analysis of the medical device industry with
emphasis on the current trends and future outlook for emerging medical
technology. Paulson was Senior Vice President and General Manager of the Auditory
Division of Advanced Bionics Corporation, and between 1995 and 2001, Mr.
MedicalCV, Inc. Jungbauer ROI Group Associates, Inc. 10 / 17
sshepard@roiny. In the summer of 2004, U. Wright 's PATH(TM)
technique does address these issues through innovative, yet simple
instrumentation that allows surgeons to achieve repeated success when
using a minimally invasive approach.

About Wright

Wright Medical Group, Inc.

skeletons 3b

Paulson is President, Chief Executive Officer and a director of
Restore Medical, Inc. Those challenges include difficulty in implant
positioning and risk of soft-tissue damage. For more information about Wright Medical, visit
our website at www.

nose anatomical

Mr . Flores, president and chief executive officer of MedicalCV Inc. Paulson joining our Board.

The Nation 's Largest Medical Device Reprocessors Reaffirm Their Commitment to Patient Safety

WASHINGTON , The Association of Medical Device
Reprocessors (AMDR), a trade association representing third-party reprocessors
of medical devices, reaffirmed its "Commitment to Patient Safety and Hospital
Customers " at their March Board meeting. We are proud to have worked with
FDA to develop regulatory requirements that are as stringent as (and, in
some cases, more stringent than) those required of original devices. The technique and instrumentation
are designed for use with Wright's PROFEMUR (R) hip system with modular
neck technology - the only hip system in the industry specially suited
for a minimally invasive surgical approach.com
This press release may contain "forward-looking statements" within
the meaning of Section 27A of the Securities Act of 1933, as amended,
and Section 21E of the Securities Exchange Act of 1934, as amended.

anesthesia throat

medcvinc.roiny.php.
Vice President, Finance + CFO Robert Giordano / Sarah Shepard
Phone 651. The list sets out the steps that
AMDR's members take to protect patient safety and educate the public about
medical device reprocessing.D.

demonstrative anesthesia

We expect them to play an important role in
shaping our strategy as we continue to develop products for the growing atrial
fibrillation market.

* Comply with all FDA adverse event reporting requirements, including
forwarding to FDA reports of events that were mistakenly sent to the
reprocessor concerning devices that were not in fact reprocessed.-- --

Limited Launch of Instrumentation and Workshops With
Surgeon-Developer , Dr. (NASDAQ:WMGI), a global orthopaedic
medical device company, today announced a limited launch of
instrumentation for its new PATH(TM) minimally invasive surgical
("MIS") technique for total hip arthroplasty at this week's American
Academy of Orthopaedic Surgeons Meeting in Washington, D .

anesthesia zoological

From 2001 to June 2002,
Mr.
Marc P. Contact: Investor Relations Contact:
John H. FDA does not require devices to be labeled for
"single use. The Company wishes
to caution readers that actual results might differ materially from
those described in the forward-looking statements.

orthopaedic knee

Robert Paulson, Jr. Haimovitch and
Mr. The Company's common stock is traded on the OTC Bulletin
Board under the symbol "MDCV.

* Monitor every reprocessed device so that hospitals and patients can be
certain that no device is reprocessed more times than the number that
has been demonstrated through strict validation studies to be
appropriate for the device model in question.

* Continue to help our hospital customers achieve substantial cost
savings, to assist them in meeting the growing patient care challenges
of their communities including charitable care needs, women and infant
programs, and otherwise unfunded community outreach programs."
Wright's ODYSSEY(TM) Tissue Preserving Initiative was introduced
in September of 2004 with a less invasive technique and
instrumentation for use with the Company's PROFEMUR(R ) Hip System.

ingmar constructing

medcvinc.roiny. More information can
be found at http://www.S. "Now Wright is very pleased to introduce these advances in
minimally invasive total hip arthroplasty to other surgeons and help
them achieve the same success.

replicates voxel

This includes informing our key audiences that the "single-use"
label on medical devices is used at the discretion of the original
equipment manufacturer . News + World Report
magazine.

Wright Medical Group Inc. To Reveal PATH Technique For Less Invasive Total Hip Arthroplasty

skeletons knee

com Phone 212. News identified 14 Honor Roll hospitals
as those outstanding medical centers that "merit acclaim for impressive
quality and breadth of expertise.

The Company
assumes no obligation to update any forward-looking statement after
this date.

anesthesia vata

"

About MedicalCV, Inc." AMDR members account for approximately 95 percent of the
third-party reprocessing done in the United States. Penenberg has performed over 125 successful total hip
replacements using the PATH(TM) technique and instrumentation," said
Aldo Denti, Vice President and General Manager of Wright's OrthoRecon
Division.

zoological respiratory

Paulson served in various capacities at Medtronic, Inc.com.com
http://www.

Commitment to Patient Safety and Hospital Customers

* Provide hospitals and patients with reprocessed devices that meet or
exceed all regulatory requirements. is a global orthopaedic medical device
company specializing in the design, manufacture and marketing of
reconstructive joint devices and biologics. The Company has been in
business for more than 50 years and markets its products in over 60
countries worldwide . The Company wishes to caution readers not to place undue
reliance on any forward-looking statement .

3b constructing

,
commented, "We are extremely pleased to have two individuals with the wealth
of experience in the medical device industry possessed by Mr.

Anatomical models are used for training and education .

ingmar breathing

Haimovitch is President of Haimovitch Medical Technology Consultants,
a San Francisco-based health care consulting firm he formed in 1990.com

The Commitment to Patient Safety includes an initiative by the
reprocessors to educate patients and the medical community that the
reprocessing of medical devices, when conducted in accordance with FDA's
stringent requirements, is a safe practice that helps hospitals control their
costs and significantly reduce their medical waste streams while allowing them
to maintain the very highest standards of patient care. The
limited launch will feature small group, hands-on workshops with the
technique and instrumentation's designer, Brad Penenberg , M.
"Dr.

orthopaedic ingmar

, a company focused on developing and marketing products
for the ear, nose and throat field. The Company acquired this
technology in August 2003 and received its FDA 510(k) clearance in November
2004.org.

About AMDR
The Association of Medical Device Reprocessors (AMDR) is a trade
association representing third-party reprocessors of medical devices labeled
for "single-use. Brad Penenberg, To Take Place at
72nd Annual American Academy of Orthopaedic Surgeons Meeting

Wright Medical Group, Inc. Forward-looking
statements reflect management's current knowledge, assumptions,
beliefs, estimates, and expectations and express management's current
views of future performance, results, and trends. Forward-looking
statements are subject to a number of risks and uncertainties,
including the factors discussed in the Company's filings with the
Securities and Exchange Commission (including the Company's annual
report on Form 10-K for the year ended December 31, 2003), which could
cause the Company's actual results to materially differ from those
described in the forward-looking statements.

constructing ingmar

as new directors, effective August 3,
2005.3000 President / Vice President
jjungbauer@medcvinc.